Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Equillium, Inc.EQ · Entity 6560 | 10% owner | October 16, 2018 | October 16, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Equillium, Inc.
Report date October 16, 2018 · Filed October 16, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,316,134 |
Reported balance
After 2018-10-16 transaction · row 1
1 source rowRow 1 · 2018-10-16 · Grant · Acquired 228,060 · Balance 2,316,134 F1: This shares were acquired pursuant to certain anti-dilution rights for no additional consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: This shares were acquired pursuant to certain anti-dilution rights for no additional consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 16, 2018 Filed Oct 16, 2018 21:35 UTC | Equillium, Inc. EQ · Entity 6560 | GrantCommon Stock | 228,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-055166 · doc4.xml · nonDerivative · entry 1 Biocon SA · CIK 0001754954 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,316,134 F1 · kind: This shares were acquired pursuant to certain anti-dilution rights for no additional consideration. F1 · price: This shares were acquired pursuant to certain anti-dilution rights for no additional consideration. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.